Computed Tomographic Coronary Angiography for Acute Chest Pain Evaluation - Study Results

Computed Tomographic Coronary Angiography for Acute Chest Pain Evaluation (EDCCTA)

This study has been terminated.

( Enrollment rate was too slow. )

Study NCT00615719 Information provided by Virginia Commonwealth University

First Received on December 25, 2007. Last Updated on December 7, 2011 History of Changes

Results First Received: August 15, 2011

Study Type:	Observational
Study Design:	Observational Model: Cohort; Time Perspective: Prospective
Conditions:	Acute Coronary Syndromes Coronary Artery Disease

Participant Flow

Recruitment Details

Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
No text entered.

Pre-Assignment Details

Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups

	Description
ED Patients Undergoing Coronary CTA	Usefulness of Computed Tomographic (CT) Coronary Angiography (CTCA) to Evaluate Emergency Department (ED) Patients With Chest Pain (EDCCTA). Patients were to undergo Coronary CT angiography in addition to the nuclear perfusion imaging performed as the standard of care.

Participant Flow: Overall Study

	ED Patients Undergoing Coronary CTA
STARTED	35
COMPLETED	30
NOT COMPLETED	5
Physician Decision	5

Baseline Characteristics

Reporting Groups

	Description
ED Patients Undergoing Coronary CTA	Usefulness of Computed Tomographic (CT) Coronary Angiography (CTCA) to Evaluate Emergency Department (ED) Patients With Chest Pain (EDCCTA). Patients were to undergo Coronary CT angiography in addition to the nuclear perfusion imaging performed as the standard of care.

Baseline Measures

	ED Patients Undergoing Coronary CTA
Number of Participants [units: participants]	35
Age [units: participants]
<=18 years	0
Between 18 and 65 years	35
>=65 years	0
Gender [units: participants]
Female	17
Male	18

Outcome Measures

1. Primary:

The Presence of Acute Coronary Syndromes(ACS). [ Time Frame: During the presenting illness, usually within two to three days. ]

Show Outcome Measure 1

Serious Adverse Events

Other Adverse Events

More Information

Certain Agreements:

All Principal Investigators ARE employed by the organization sponsoring the study.

Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
Early termination leading to small numbers of subjects analyzed

Results Point of Contact:

Name/Title: John D. Grizzard
Organization: VCU
phone: 804-828-8569
e-mail: jdgrizzard@vcu.edu

No publications provided

Responsible Party:	Virginia Commonwealth University
ClinicalTrials.gov Identifier:	NCT00615719 History of Changes
Other Study ID Numbers:	20061756, PT101207
Study First Received:	December 25, 2007
Results First Received:	August 15, 2011
Last Updated:	December 7, 2011
Health Authority:	United States: Institutional Review Board